Acrotech Launches ADQUEY, Enters U.S. Dermatology Market
Acrotech has launched ADQUEY™, its new dermatology brand, marking the company's first entry into the U.S. dermatology market.
Section
Company news, product launches and regulatory action in skin care.
Acrotech has launched ADQUEY™, its new dermatology brand, marking the company's first entry into the U.S. dermatology market.
Biofrontera has submitted an sNDA to the FDA seeking approval of Ameluz PDT for actinic keratoses on body areas beyond its curren…
L'Oréal is weighing options to offload talc liabilities as 12,636 US hair-relaxer cases and 760 talc proceedings stack up. Arizon…
FDA approves revised Kybella labeling flagging injection-site nodules, masses larger than 3 cm, and neuromuscular adverse events…
The Observer editorial opens with the line 'Sunbeds cause cancer. Social media has to stop pushing them' and demands platforms cu…
Dermatology Times has published "Don't Be Rash: What UV Filter Bemotrizinol Means for Children," revisiting pediatric sunscreen f…
Olehenriksen opens its 'Scandiland' pop-up in New York on 9–10 October to launch the Scandi Candy Pout Preserve Peptide Lip Treat…
Korea's 2026 National Assembly audit counted 1.54 million foreign dermatology and plastic surgery patients, with cosmetic surgery…
Hugel targets 1 trillion won in sales within three years, staking its growth plan on the Korean aesthetics maker's injectable por…
Eli Lilly is looking to add aesthetics products for body, skin and hair, Endpoints News reports, positioning the drugmaker to com…